Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Evert

Showing results (101-110 of 228) with videos related to

Pageof 23
Sort By:
International Journal of Molecular Sciences|February 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular CarcinomaSara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for TherapyAlexander Scheiter, Felix Keil, Florian Lüke, et al.
Cell Death & Disease|February 6, 2020
Oncogene-dependent function of BRG1 in hepatocarcinogenesisPan Wang, Xinhua Song, Dan Cao, et al.
Journal of Hypertension|October 3, 2014
Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorptionOlaf Grisk, Anna Koenen, Thomas Meissner, et al.
International Journal of Molecular Sciences|September 27, 2016
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsSilvia Ribback, Verena Sailer, Enrico Böhning, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 17, 2022
Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma DevelopmentMarina Serra, Mario Di Matteo, Jens Serneels, et al.
Journal of Cellular and Molecular Medicine|March 28, 2008
Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer modelsHala Gali-Muhtasib, Matthias Ocker, Doerthe Kuester, et al.
Aktuelle Urologie|April 20, 2017
[Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma]Johannes Breyer, Wolfgang Otto, Eva Maria Lausenmeyer, et al.
Oncotarget|December 25, 2014
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in miceSalvatore Delogu, Chunmei Wang, Antonio Cigliano, et al.
Hepatology (Baltimore, Md.)|January 25, 2022
Therapeutic efficacy of FASN inhibition in preclinical models of HCCHaichuan Wang, Yi Zhou, Hongwei Xu, et al.
Pageof 23

Showing results (101-110 of 228) with videos related to

Sort By:
Pageof 23
International Journal of Molecular Sciences|February 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular CarcinomaSara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for TherapyAlexander Scheiter, Felix Keil, Florian Lüke, et al.
Cell Death & Disease|February 6, 2020
Oncogene-dependent function of BRG1 in hepatocarcinogenesisPan Wang, Xinhua Song, Dan Cao, et al.
Journal of Hypertension|October 3, 2014
Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorptionOlaf Grisk, Anna Koenen, Thomas Meissner, et al.
International Journal of Molecular Sciences|September 27, 2016
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsSilvia Ribback, Verena Sailer, Enrico Böhning, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 17, 2022
Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma DevelopmentMarina Serra, Mario Di Matteo, Jens Serneels, et al.
Journal of Cellular and Molecular Medicine|March 28, 2008
Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer modelsHala Gali-Muhtasib, Matthias Ocker, Doerthe Kuester, et al.
Aktuelle Urologie|April 20, 2017
[Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma]Johannes Breyer, Wolfgang Otto, Eva Maria Lausenmeyer, et al.
Oncotarget|December 25, 2014
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in miceSalvatore Delogu, Chunmei Wang, Antonio Cigliano, et al.
Hepatology (Baltimore, Md.)|January 25, 2022
Therapeutic efficacy of FASN inhibition in preclinical models of HCCHaichuan Wang, Yi Zhou, Hongwei Xu, et al.
Pageof 23